Clinical Trial Update: Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update comparing liraglutide-bolus therapy with insulin glargine-bolus therapy in overweight/obese patients with Type 2 diabetes; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperglycemia
• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (insulin glargine)
• liraglutide (liraglutide)

Snippet

Sponsor: The First Affiliated Hospital of Xiamen University | Conditions: Type 2 Diabetes Patients, Overweight and Obesity | Phase 4 | Status: RECRUITING